How many institutions own PCSA stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PCSA shares is 14, representing 5.99% of the company's common stock.

Who are the major shareholders selling Processa Pharmaceuticals, Inc. stock?

JPMORGAN CHASE & CO, in the last quarter, reduced its stake in PCSA by -100% restricting it's holding to 0 shares of worth nearly -. VANGUARD GROUP INC also lessened -31.87% of the PCSA shares from its portfolio, reducing its holding to 234.65 thousand shares of worth $78.52K. ROYAL BANK OF CANADA also shunned PCSA shares holding by -0.16% last quarter which brought its holding to 46.31 thousand shares worth $15.00K.

Investors who are buying PCSA stock?

As per its latest 13F filing, CITADEL ADVISORS LLC increased its stake in PCSA by 89.75% in the last quarter. The institutional holder raised its holding to 315.41 thousand shares having worth more than $105.54K. SPINNAKER TRUST also added 100% more shares of PCSA to its portfolio, raising its holding to 76.87 thousand shares of worth $25.72K. COASTAL BRIDGE ADVISORS, LLC also increased its PCSA shares holding by 23.73% which brought its holding to 64.96 thousand shares worth $21.73K.

PCSA's major insiders: who are they?

The insider with the most stakes in PCSA is BESSER JAMES E , at the company. Additionally, PCSA stock is highly held by Chief Financial Officer Stanker James H and Chief Operating Officer Floyd Robert Michael among others.

Did an insider recently sell PCSA stock?

Company executives, directors, and other insiders own 12.08% percent of Processa Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which PCSA insiders have sold stock, totaling 0 shares. Insiders that have sold shares include YORKE JUSTIN W and BESSER JAMES E.

Which insider recently purchased PCSA stock?

There have been 21 transaction(s) during the past 6-months in which Processa Pharmaceuticals, Inc. insiders have bought stock, totalling 38262 shares

How much of PCSA does insiders own?

Around 112.35K Processa Pharmaceuticals, Inc. shares are held by insiders, which represents about 12.08% of PCSA stock.

Who is the insider with the largest stake?

PCSA , BESSER JAMES E holds the largest portfolio of the company's shares. PCSA shares owned by BESSER total nearly 648.3 thousand.

Which institution holds the most shares in PCSA?

JPMORGAN CHASE & CO is the largest institutional owner in PCSA which holds 0 shares worth - or 0% of the total PCSA shares outstanding followed by CITADEL ADVISORS LLC with ownership of 315.41 thousand shares representing 1.17% of the PCSA ownership. VANGUARD GROUP INC is the third largest stakeholder with 234.65 thousand shares or 0.87% of the ownership worth more than $78.52K.

Is Processa Pharmaceuticals, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PCSA is concerned, it is a stock which is not optionable.

Is there a short position on PCSA's shares?

Number of PCSA shares short is 1.74M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding PCSA shares are there?

As of today, 50.35M shares of PCSA are outstanding.

Is there many float in PCSA stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PCSA has 42.59M shares in float.

PCSA short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PCSA is 0.31.

Processa Pharmaceuticals (PCSA) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares3.45

Short Percent Of Float3.49

Shares Outstanding50.35M

Shares Float42.59M

Shares Short1.74M

Short Ratio0.31

3.49%

Short % of Float

3.45%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

12.08% Percentage of Shares held by All Insiders

5.99% Percentage of Shares held by All Institutions

6.82% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 5.99% of PCSA shares are held by financial institutions. JPMORGAN CHASE & CO is the top corporate investor, holding 0 shares valued at -. A 0% stake in Processa Pharmaceuticals, Inc. is owned by the company. CITADEL ADVISORS LLC owns 315.41K shares valued at $105.54K, which translates its holding of 1.17% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Dec 31, 2023	JPMORGAN CHASE & CO	0%	0	-	-20	-100.00%
Dec 31, 2023	CITADEL ADVISORS LLC	1.17%	315.41K	105.54K	149.19K	+89.75%
Dec 31, 2023	VANGUARD GROUP INC	0.87%	234.65K	78.52K	-109.77K	-31.87%
Dec 31, 2023	SPINNAKER TRUST	0.28%	76.87K	25.72K	76.87K	+100.00%
Dec 31, 2023	ROYAL BANK OF CANADA	0.17%	46.31K	15K	-76	-0.16%
Dec 31, 2023	STATE STREET CORP	0.16%	42.79K	14.32K	0	0
Dec 31, 2023	HRT FINANCIAL LP	0.04%	11.72K	3K	-7.63K	-39.43%
Dec 31, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	1.2K	400	-8.9K	-88.16%
Dec 31, 2023	COASTAL BRIDGE ADVISORS, LLC	0.24%	64.96K	21.73K	12.46K	+23.73%
Dec 31, 2023	RENAISSANCE TECHNOLOGIES LLC	0.22%	58.2K	19K	4.3K	+7.98%
Dec 31, 2023	MILLENNIUM MANAGEMENT LLC	0%	0	-	-25.93K	-100.00%
Dec 31, 2023	MACROVIEW INVESTMENT MANAGEMENT LLC	0%	0	-	-12	-100.00%
Dec 31, 2023	GEODE CAPITAL MANAGEMENT, LLC	0.45%	122.03K	40.83K	-30.64K	-20.07%
Dec 31, 2023	UBS GROUP AG	0.3%	80.02K	26.81K	79.32K	+11,218.67%
Dec 31, 2023	NORTHERN TRUST CORP	0.1%	28.14K	9.42K	12.74K	+82.71%
Dec 31, 2023	TWO SIGMA INVESTMENTS, LP	0.07%	18.68K	6.25K	18.68K	+100.00%
Dec 31, 2023	MCCOLLUM CHRISTOFERSON GROUP LLC	0.05%	12.5K	4.18K	12.5K	+100.00%
Dec 31, 2023	COURIER CAPITAL LLC	0.04%	12K	4.02K	12K	+100.00%
Dec 31, 2023	WELLS FARGO & COMPANY/MN	0.01%	3.25K	1.09K	9	+0.28%
Dec 31, 2023	ALLWORTH FINANCIAL LP	0.01%	1.7K	569	0	0
Dec 31, 2023	BLACKROCK INC.	0%	293	98	0	0
Dec 31, 2023	VIRTU FINANCIAL LLC	0%	0	-	-11.62K	-100.00%
Dec 31, 2023	MIRADOR CAPITAL PARTNERS LP	0%	0	-	-19.52K	-100.00%
Dec 31, 2023	WALLEYE CAPITAL LLC	0%	0	-	-419.28K	-100.00%

Insiders

Among the PCSA insiders holding of 12.08% of the stake in company, BESSER JAMES E, , holds the largest shares of 648.3K. STANKER JAMES H, Chief Financial Officer, is the second largest PCSA insider with ownership of 36.51K shares. FLOYD ROBERT MICHAEL, Chief Operating Officer, stands third with possession of 28K shares of that stake.

Insiders	Designation	Shares Held
BESSER JAMES E		648.3K
STANKER JAMES H	Chief Financial Officer	36.51K
FLOYD ROBERT MICHAEL	Chief Operating Officer	28K
YOUNG DAVID	Pres. Research & Development	13.81K
YORKE JUSTIN W	director	12.4K
BIGORA SIAN	Chief Development Officer	7.5K
SKIBSTED RUSSELL	Chief Financial Officer	6.5K
GUY WENDY	Chief Administrative Officer	6.44K
LIN PATRICK	Chief Business - Strategy Off	6.24K
NG GEORGE K	Chief Executive Officer	6.01K
BALUCH KHOSO	director	2.33K
PANNU GERALDINE	director	2.19K
NEAL JAMES R	director	818

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Apr 30, 2026	YOUNG DAVID	PURCHASE	2.69	1.71K	4.59K	13.81K
Apr 30, 2026	BIGORA SIAN	PURCHASE	2.69	1.99K	5.34K	7.5K
Apr 30, 2026	GUY WENDY	PURCHASE	2.69	1.75K	4.7K	6.44K
Apr 30, 2026	LIN PATRICK	PURCHASE	2.69	1.51K	4.06K	6.24K
Apr 30, 2026	NG GEORGE K	PURCHASE	2.69	2.03K	5.47K	6.01K
Apr 30, 2026	SKIBSTED RUSSELL	PURCHASE	2.69	2.19K	5.89K	6.5K
Apr 15, 2026	NG GEORGE K	PURCHASE	2.97	1.84K	5.47K	3.98K
Apr 15, 2026	SKIBSTED RUSSELL	PURCHASE	2.97	1.98K	5.89K	4.31K
Apr 15, 2026	BIGORA SIAN	PURCHASE	2.97	1.8K	5.34K	5.51K
Apr 15, 2026	GUY WENDY	PURCHASE	2.97	1.58K	4.7K	4.69K
Apr 15, 2026	LIN PATRICK	PURCHASE	2.97	1.37K	4.07K	4.73K
Apr 15, 2026	YOUNG DAVID	PURCHASE	2.97	1.55K	4.59K	12.11K
Mar 31, 2026	SKIBSTED RUSSELL	PURCHASE	2.54	2.32K	5.89K	2.32K
Mar 31, 2026	NEAL JAMES R	PURCHASE	2.54	789	2K	818
Mar 31, 2026	YOUNG DAVID	PURCHASE	2.54	1.81K	4.59K	10.56K
Mar 31, 2026	BALUCH KHOSO	PURCHASE	2.54	2.27K	5.75K	2.33K
Mar 31, 2026	BIGORA SIAN	PURCHASE	2.54	2.11K	5.34K	3.71K
Mar 31, 2026	GUY WENDY	PURCHASE	2.54	1.85K	4.7K	3.11K
Mar 31, 2026	LIN PATRICK	PURCHASE	2.54	1.6K	4.06K	3.36K
Mar 31, 2026	NG GEORGE K	PURCHASE	2.54	2.14K	5.41K	2.14K
Mar 31, 2026	PANNU GERALDINE	PURCHASE	2.54	2.07K	5.25K	2.19K
Jan 27, 2025	YORKE JUSTIN W	PURCHASE	0.80	12.4K	9.89K	12.4K
Jan 27, 2025	YOUNG DAVID	PURCHASE	0.80	124.5K	99.29K	205.41K
Jan 27, 2025	LIN PATRICK	PURCHASE	0.80	43.5K	34.69K	43.5K
Jan 27, 2025	NG GEORGE K	PURCHASE	0.80	87.2K	69.54K	87.2K
Feb 07, 2024	YOUNG DAVID	PURCHASE	2.45	21K	51.53K	79.39K
Feb 06, 2024	YOUNG DAVID	PURCHASE	2.53	20K	50.5K	58.39K
Feb 01, 2024	LIN PATRICK	PURCHASE	2.40	1.5K	3.6K	27.48K
Jan 31, 2024	LIN PATRICK	PURCHASE	2.37	2.5K	5.93K	25.98K
Jan 30, 2024	NG GEORGE K	PURCHASE	2.70	10K	27K	20K
Jan 30, 2024	YORKE JUSTIN W	PURCHASE	2.69	8K	21.54K	31.23K
Jun 12, 2023	YOUNG DAVID	PURCHASE	0.80	40K	32K	470.42K
Apr 14, 2023	YOUNG DAVID	PURCHASE	0.55	20K	11K	430.42K
Apr 13, 2023	YOUNG DAVID	PURCHASE	0.48	20K	9.6K	410.42K
Apr 12, 2023	YOUNG DAVID	PURCHASE	0.45	20K	9K	390.42K
Apr 11, 2023	YOUNG DAVID	PURCHASE	0.52	20K	10.4K	370.42K
May 17, 2022	LIN PATRICK	PURCHASE	1.59	2K	3.19K	433.39K
Apr 06, 2022	LIN PATRICK	PURCHASE	3.13	1.2K	3.75K	430.59K
Jan 27, 2022	YORKE JUSTIN W	SALE	3.30	1.85K	6.12K	532.56K
Dec 14, 2021	LIN PATRICK	PURCHASE	4.00	3K	12K	429.39K
Dec 06, 2021	YORKE JUSTIN W	SALE	4.71	4.2K	19.78K	534.42K
Dec 03, 2021	YORKE JUSTIN W	SALE	4.84	5.5K	26.6K	538.62K
Dec 03, 2021	LIN PATRICK	PURCHASE	4.80	3.5K	16.8K	426.39K
Aug 26, 2021	LIN PATRICK	PURCHASE	6.02	4K	24.09K	422.89K
Jun 23, 2021	YOUNG DAVID	PURCHASE	7.67	10K	76.72K	345.19K
Jun 22, 2021	FLOYD ROBERT MICHAEL	PURCHASE	7.03	2K	14.06K	28K
Jun 21, 2021	LIN PATRICK	PURCHASE	6.65	2K	13.3K	401.74K
Jun 21, 2021	STANKER JAMES H	PURCHASE	6.81	1K	6.81K	36.51K
Apr 14, 2021	YORKE JUSTIN W	SALE	9.42	9.7K	91.37K	248.27K
Apr 13, 2021	YORKE JUSTIN W	SALE	9.86	6.5K	64.09K	257.97K
Apr 08, 2021	BESSER JAMES E	SALE	10.76	400K	4.3M	648.3K
Apr 07, 2021	BESSER JAMES E	SALE	10.67	16K	170.72K	1.05M
Apr 06, 2021	BESSER JAMES E	SALE	10.91	31.77K	346.62K	1.06M
Feb 22, 2021	BESSER JAMES E	SALE	11.56	20.93K	241.94K	1.1M
Feb 19, 2021	BESSER JAMES E	SALE	11.20	3K	33.6K	1.12M
Feb 18, 2021	BESSER JAMES E	SALE	11.35	5K	56.75K	1.12M
Oct 02, 2020	BESSER JAMES E	PURCHASE	4.04	30K	121.2K	405K
Oct 01, 2020	STANKER JAMES H	PURCHASE	2.10	6K	12.6K	47.25K
Oct 01, 2020	LIN PATRICK	PURCHASE	2.10	31.25K	65.63K	399.74K

Insider Transaction Summary (6 Months)

SHARESTRANS

PURCHASE38.26K21

SALES00

NET SHARES38.26K21

SHARES HELD112.35K21

% NET SHARES-65.94%0%

PCSA Stock Ownership Breakdown